Skip to main content

Greenberg Traurig Adds Seasoned Corporate Shareholder Carl Berglind in Denver

DENVER – April 14, 2021 – Global law firm Greenberg Traurig, LLP has expanded its Denver office with the addition of Carl F. Berglind as a shareholder in the Corporate; Health Care & FDA; and Food, Beverage & Agribusiness Practices. Berglind is a seasoned corporate attorney with 20 years of experience spanning national law firms, senior in-house practice, and executive business positions. He formerly served as the CEO of Livestock Labs, an agriculture technology company with applications for the animal health sector.

“A proven leader, Carl has held key roles in high-stakes public and private companies and will serve as a key resource for clients. His significant, well-rounded corporate experience in a variety of sectors, including the rapidly evolving health care industry, will be a tremendous asset to clients in Denver and across the firm,” said Co-Chairs of Greenberg Traurig’s Health Care & FDA Practice David C. Peck and Nancy E. Taylor in a joint statement.

While overseeing personnel in the United States and Australia as CEO, Berglind led Livestock Labs’ strategic initiatives, helped the company advance its technology, and developed critical relationships for the company.

“Carl brings significant experience in key industries and strong relationships in the Denver business community and beyond,” said Denver Co-Managing Shareholders David G. Palmer and Michael R. McGinnis in a joint statement “We are proud to welcome him to Greenberg Traurig as we continue to expand our dynamic Denver office.”

Prior to Livestock Labs, Berglind served as vice president of mergers and acquisitions for CVP, a private equity-backed ophthalmology management services organization; and as senior vice president of strategic transactions for Envision Healthcare, a then publicly traded U.S. healthcare services company. During his time at Envision Healthcare, Berglind also served as associate general counsel and corporate counsel, holding leading responsibilities in the mergers and acquisitions (M&A), securities, and international practice areas. At Envision Healthcare, he closed 50 M&A transactions between his legal and business roles.

Berglind also has experience at the law firms of Hogan Lovells, LLP, and Morrison & Foerster, LLP, where he focused his practice on M&A, venture capital, and private equity, and securities matters. He has represented acquirers and sellers in public and private M&A transactions in a diverse range of industries. He also has experience advising issuers and investors in equity financings and counseling public and private clients on corporate governance matters and public reporting obligations.

He earned a J.D. from Cornell Law School, and his B.A., summa cum laude, from Boston University.

“I am excited to work with Greenberg Traurig’s deep bench of talented attorneys,” Berglind said. “In transitioning back to private practice, I was drawn to the firm’s global platform of resources and its culture of collaboration, innovation, and success.”

About Greenberg Traurig’s Health Care & FDA Practice: Greenberg Traurig’s multidisciplinary Health Care & FDA Practice provides strategic counsel to a diverse group of companies and other organizations, helping them to respond proactively to the rapidly changing healthcare marketplace. The group combines dedicated experience in health care regulatory compliance and operational matters with the firm’s capabilities in corporate & securities, finance, tax, antitrust, ERISA, commercial and governmental litigation, restructuring, intellectual property and biotechnology, in order to provide a wide range of legal services.

About Greenberg Traurig’s Corporate Practice: Greenberg Traurig’s Corporate Practice comprises more than 450 lawyers in the United States, Europe, Asia, the Middle East and Latin America who regularly advise public and privately held companies, entrepreneurs and investment funds on global mergers and acquisitions, corporate restructurings, private equity and venture capital, underwritten and syndicated offerings, commercial finance and syndicated lending, cross-border transactions, and general corporate matters. The group’s industry experience includes transactions in a wide range of fields, from the pharmaceutical, medical devices, and life sciences fields, to representations involving clients in the aviation, banking, consumer products, energy, food and beverage, health care, manufacturing, media, technology, and telecommunications sectors.

About Greenberg Traurig’s Food, Beverage & Agribusiness Practice: Greenberg Traurig's Food, Beverage & Agribusiness Practice leverages their deep experience representing some of the most significant participants in the food, beverage, agribusiness, dietary supplement, and personal care products industries. The Agribusiness team is globally ranked in Chambers & Partners, and Law360 has named them a “Food & Beverage Practice Group of the Year,” with a team member being recognized as a Law360 MVP for Food & Beverage. They represent clients on a broad range of matters in the sector, including those involving agrotech, environmental, finance, intellectual property, labor and employment, litigation, M&A, real estate, regulatory, restructuring, and tax matters.

About Greenberg Traurig: Greenberg Traurig, LLP (GT) has approximately 2200 attorneys in 40 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. The firm is net carbon neutral with respect to its office energy usage and Mansfield Rule 3.0 Certified. Web: